In silico assessment of chronic toxicity of a combination drug namely 'Olmesartan medoxomil and Hydrochlorothiazide', marketed in Bangladesh

• Prif Awduron: Matrika Saha Roy (Awdur), Rehnuma Tanjin (Awdur), Tanmoy Debnath (Awdur), Bidduth Kumar Sarkar (Awdur), Prema Modak (Awdur), Milon Mondal (Awdur), Arghya Prosun Sarkar (Awdur), Md Ariful Islam (Awdur), Sukalyan Kumar Kundu (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: SpringerOpen, 2021-12-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract Background Nowadays combination therapy has become more popular due to their additional effect, synergistic effect and antagonistic effect. Any of these can influence the treatment profile. Combination therapy is used to treat some chronic diseases like diabetes, hypertension, cancer etc. B...